7/20/2020CDE Issues the Clinical Research Guidelines for Trastuzumab Biosimilar...

7/20/2020CDE Issues the Guideline on the Submission of Clinical Trial Data

7/17/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...

7/16/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...

7/14/2020CDE Solicits Comments on the Draft Technical Guidelines for Pharmaceut...

7/14/2020CDE Issues the Guidelines for Drug Clinical Trials During Novel Corona...

7/10/2020CDE Launches Updated Drug Clinical Trial Registration and Information ...

7/10/2020CDE Launches Online Application Systems for Breakthrough Medicines and...

7/9/2020CDE Issues the Guidelines for Format/Style and Collation of Drug Admin...

7/8/2020NMPA Issues the Working Procedure for Priority Review and Approval of ...

7/8/2020NMPA Issues Working Procedures for Drug Marketing Evaluation and Appro...

7/8/2020NMPA Issues Working Procedures for Evaluation and Approval of Breakthr...

7/6/2020CDE Solicits Comments on the Draft Writing Guide and Common Format of ...

7/6/2020CDE Solicits Comments on the Draft Technical Guidelines for Marketing ...

7/6/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...

7/3/2020CDE Issues Interim Guidelines for Registration Acceptance and Evaluati...

7/2/2020NIFDC Issues the Guideline for the Working Procedures and Technical Re...

7/2/2020NMPA and NHC Introduce the 2020 Edition of Chinese Pharmacopoeia

7/2/2020NMPA Issues the Amended Blood Product Appendix of 2010 GMP

7/1/2020CDE Solicits Comments on the Draft CDE Guidelines for Management of Su...

7/1/2020CDE Issues the M4 Module 1. Administrative Information and Prescribing...

7/1/2020CDE Issues the Guidelines for Safety Update Reporting During R&amp...

7/1/2020CDE Issues the Guidelines for Evaluation and Management of Safety Info...

7/1/2020CDE Issues the Guidelines for Clinical Trial Registration and Informat...

7/1/2020NMPA Issues the Requirements for Drug Record and Data Management (Inte...

7/1/2020NMPA Issues Announcement on Drug Registration Fee Standards and Rules

7/1/2020NMPA Reports on Crackdown of Fake and Substandard Drugs in 2019

6/30/2020NMPA Issues the Chemical Drug Registration Classification and Dossier ...

6/30/2020NMPA Issues the Biologic Product Registration Classification and Dossi...

6/30/2020NMPA Publicizes the List of Reference Formulations for Generic Drug Eq...

Page:4/9 Total number of articles:247: [First][<<] [2] [3] [4] [5] [6] [>>] [End]